A large pharmaceutical company pays a researcher at a
university consulting fees of $10,000 per year, and once or twice a year an
honoraria of about $3,000 to give a talk. The same researcher also serves on
one of the FDA advisory councils.
• Do you have any concerns? What are they?
• How should these concerns, if any, be managed?
Leave a Reply